Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic avenue for managing metabolic disorders. These naturally approved peptide manufacturer. occurring hormones are secreted by the gut in response to nutrient intake, stimulating insulin release and suppressing glucagon output. GLP-1 derivatives exhibit promising therape